Additional studies have shown that PTX3 treatment after traumatic brain injury can activate the beneficial type 2 astrocytes, enhance neuroprotection and neurogenesis, and improve functional recovery (Zhou et al., 2020). This evidence concerns the gene PTX3 and brain injury.